Katsuhiko Sekimata

Affiliations
  • RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan.

Publications (6)

The ubiquinone synthesis pathway is a promising drug target for Chagas disease.

PloS one
Avec: Takeshi Nara , Yukari Nakagawa , Keiko Tsuganezawa , Hitomi Yuki , Katsuhiko Sekimata , Hiroo Koyama , Naoko Ogawa , Teruki Honma , Mikako Shirouzu , Takehiro Fukami , Yuichi Matsuo , Daniel Ken Inaoka , Kiyoshi Kita , Akiko Tanaka

Structural Basis of Activin Receptor-Like Kinase 2 (R206H) Inhibition by Bis-heteroaryl Pyrazole-Based Inhibitors for the Treatment of Fibrodysplasia Ossificans Progressiva Identified by the Integration of Ligand-Based and Structure-Based Drug Design Approaches.

ACS omega
Avec: Tomohiro Sato , Katsuhiko Sekimata , Naoki Sakai , Hisami Watanabe , Chiemi Mishima-Tsumagari , Tomonori Taguri , Takehisa Matsumoto , Yoshifumi Fujii , Noriko Handa , Akiko Tanaka , Mikako Shirouzu , Shigeyuki Yokoyama , Yoshinobu Hashizume , Kohei Miyazono , Hiroo Koyama , Teruki Honma

Identification of small molecule inhibitors of human COQ7.

Bioorganic & medicinal chemistry
Avec: Keiko Tsuganezawa , Katsuhiko Sekimata , Yukari Nakagawa , Rei Utata , Kana Nakamura , Naoko Ogawa , Hiroo Koyama , Mikako Shirouzu , Takehiro Fukami , Kiyoshi Kita , Akiko Tanaka

Novel bicyclic pyrazoles as potent ALK2 (R206H) inhibitors for the treatment of fibrodysplasia ossificans progressiva.

Bioorganic & medicinal chemistry letters
Avec: Hirofumi Yamamoto , Naoki Sakai , Satoshi Ohte , Tomohiro Sato , Katsuhiko Sekimata , Takehisa Matsumoto , Kana Nakamura , Hisami Watanabe , Chiemi Mishima-Tsumagari , Akiko Tanaka , Yoshinobu Hashizume , Teruki Honma , Takenobu Katagiri , Kohei Miyazono , Hiroshi Tomoda , Mikako Shirouzu , Hiroo Koyama

Bis-Heteroaryl Pyrazoles: Identification of Orally Bioavailable Inhibitors of Activin Receptor-Like Kinase-2 (R206H).

Chemical & pharmaceutical bulletin
Avec: Katsuhiko Sekimata , Tomohiro Sato , Naoki Sakai , Hisami Watanabe , Chiemi Mishima-Tsumagari , Tomonori Taguri , Takehisa Matsumoto , Yoshifumi Fujii , Noriko Handa , Teruki Honma , Akiko Tanaka , Mikako Shirouzu , Shigeyuki Yokoyama , Kohei Miyazono , Yoshinobu Hashizume , Hiroo Koyama

ALK2: A Therapeutic Target for Fibrodysplasia Ossificans Progressiva and Diffuse Intrinsic Pontine Glioma.

Chemical & pharmaceutical bulletin
Avec: Katsuhiko Sekimata , Tomohiro Sato , Naoki Sakai

Réseau de co-auteurs

Hiroo Koyama 5 collaborations
Mikako Shirouzu 5 collaborations
Akiko Tanaka 5 collaborations
Teruki Honma 4 collaborations
Tomohiro Sato 4 collaborations
Naoki Sakai 4 collaborations
Hisami Watanabe 3 collaborations
Chiemi Mishima-Tsumagari 3 collaborations
Takehisa Matsumoto 3 collaborations
Yoshinobu Hashizume 3 collaborations
Kohei Miyazono 3 collaborations
Yukari Nakagawa 2 collaborations
Keiko Tsuganezawa 2 collaborations
Naoko Ogawa 2 collaborations
Takehiro Fukami 2 collaborations
Kiyoshi Kita 2 collaborations
Tomonori Taguri 2 collaborations
Yoshifumi Fujii 2 collaborations
Noriko Handa 2 collaborations
Shigeyuki Yokoyama 2 collaborations
Kana Nakamura 2 collaborations
Takeshi Nara 1 collaboration
Hitomi Yuki 1 collaboration
Yuichi Matsuo 1 collaboration
Daniel Ken Inaoka 1 collaboration
Rei Utata 1 collaboration
Hirofumi Yamamoto 1 collaboration
Satoshi Ohte 1 collaboration
Takenobu Katagiri 1 collaboration
Hiroshi Tomoda 1 collaboration